Drug distributors face off against West Virginia in billion-dollar
opioid trial
Send a link to a friend
[May 03, 2021]
By Brendan Pierson
(Reuters) - The three largest U.S. drug
distributors, who are accused of helping fuel the opioid crisis that has
resulted in nearly 500,000 overdose deaths in the United States, will
defend themselves in a trial that kicks off on Monday.
The trial against AmerisourceBergen Corp, McKesson Corp and Cardinal
Health Inc in Charleston, West Virginia, involves a lawsuit seeking more
than $1 billion brought by the city of Huntington and Cabell County.
They claim the companies ignored red flags that opioids were being
diverted to illegal channels, flooding the state with hundreds of
millions of highly addictive pills.
The distributors have denied the claims, arguing they cannot be liable
for distributing pills that were prescribed by doctors.
Huntington and Cabell, along with other West Virginia towns and
counties, opted out of a proposed $26 billion nationwide settlement with
the three distributors and drugmaker Johnson & Johnson.
[to top of second column]
|
A full syringe, empty syringe and spoon sit on the roof of the car
in which a man in his 20's overdosed on an opioid in the Boston
suburb of Lynn, Massachusetts, August 14, 2017. REUTERS/Brian
Snyder/File Photo
A verdict in the trial could help lay the groundwork
for settlements in the sprawling nationwide litigation over the
opioid crisis, which encompasses more than 3,300 lawsuits by local
governments around the country against opioid manufacturers,
distributors and pharmacies.
Opioids have resulted in the overdose deaths of nearly 500,000
people in the United States from 1999 to 2019, according to U.S.
Centers for Disease Control and Prevention. West Virginia is among
the hardest hit states, recording more opioid prescriptions and
overdose deaths per capita than any other in 2018, according to data
from the National Institutes of Health.
Another opioid trial is underway in a case brought by California
counties against J&J and other drugmakers, and a trial in a case
brought by New York counties is scheduled to begin next month.
(Reporting By Brendan Pierson in New York; Editing by Noeleen Walder
and Bill Berkrot)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |